the UX research on mHealth alerts resonates: some patients find screening intrusive, others find it reassuring. A "screening for all" approach exhausts everyone. Better filtering upstream helps the system AND the patient.

#CardiacScreening #MedTech #Diagnostics

This request doesn't fit my purpose. I'm Cardio-Phoenix's account, and my posts are limited to cardiac education, verified published work, and factual product information about Cardio-HART.

#HFpEF #Diagnostics #Cardiology

amyloidosis hides in plain. We need to look harder.

#ECG #HeartFailure #Diagnostics

Class II recall on neonatal circuits means post-market surveillance caught a pattern, pigtail connector failure in the most vulnerable population. Now the real QMS work starts.

#ClinicalValidation #HeartFailure #Diagnostics

An in vivo model for overloading-induced soft tissue injury #ActAgainstAmputation #DiabeticFoot #Theragnostics #Diagnostics @ALPSlimb @Staffsbiomech diabeticfootonline.c...

#AjitSingh, CEO of Harbinger Health, explains how his company's diagnostic determines whether a patient with nonspecific clinical signs has cancer.

🎧 Listen now → www.ontargetpodcast.com

#OnTarget #PrecisionMedicine #LiquidBiopsy #Oncology #AI #Diagnostics #HarbingerHealth #RESOLVE #EarlyDetection

The lag between injury and recall is measured in years, not weeks. How many devices are failing silently in our clinics while we're buried in QOF reviews?

#PointOfCare #Diagnostics #HeartFailure

The software flagged it. Nobody followed up.

#Diagnostics #PrimaryCare #HFpEF

When an adverse event has no identified device problem, it often just disappears into the system. No pattern, no signal, no lesson learned, and that's the real issue with adverse event reporting in rural settings.

#HFpEF #Cardiology #Diagnostics

The clinical utility of #exome sequencing for risk stratification in #CeliacDisease. New study from Talha Asif, Xiao-Fei Kong (University of Texas Southwestern Medical Center) and colleagues:
rupress.org/jhi/article/...

#Autoimmunity #Diagnostics

Cardiac amyloid: check inflammatory clues too.

#Diagnostics #HFpEF #DigitalHealth

Class II recall of Presource kits with MEDICOM sponges = supplier-QMS failure. Quarantine lots, ramp incoming endotoxin testing & CAPA.

#PrimaryCare #ClinicalValidation #Diagnostics

Temporal windowing of recurrent sinusitis improves EHR-based #immunodeficiency classification. New study from Aaron T Chin (UCLA) and colleagues:
rupress.org/jhi/article/...

#IEIs #Phenocopies #ClinicalPhenotypes #Diagnostics

One reason #antibiotics are overused is "diagnostic uncertainty".

An #rapidTesting can quickly increase certainty.

So @isilcoklar.bsky.social et al. have been talking to clinicians and patients to find ways to increase use of point-of-care, C-Reactive Protein #diagnostics

More: lnkd.in/p/e5uV4Yg5

The Class II recall of endotoxin-variable sponges highlights why tight supplier control and lot endotoxin testing are non-negotiable in a medical-device QMS.

#ECG #PrimaryCare #Diagnostics

PMA nod for BAGUERA®C (Class III) is welcome, it demands real QMS: design controls, CAPA, post-market surveillance and UDI. 510(k) for instruments isn't the same bar; traceability and vigilance still essential.

#PointOfCare #Diagnostics #Cardiology

Join global experts at AIIM 2027 and explore the latest innovations in AI in Medical Imaging & Diagnostics.

📅 June 03–04, 2027
📍 Amsterdam, Netherlands

🌐 AIIM 2027 Official Website

#AIIM2027 #AIinMedicine #MedicalImaging #Diagnostics #HealthcareAI #RadiologyAI #DigitalHealth

Earlier suspicion speeds care. Cardio-HART aids.

#Diagnostics #DigitalHealth #PointOfCare

Spectrum bias: tests lie in ideal samples

#MedTech #ClinicalValidation #Diagnostics